Clinical determinants of aspirin resistance in diabetes

Hussein N. Yassine, Grace Davis-Gorman, Craig S. Stump, Stephen S. Thomson, Justin Peterson, Paul F. McDonagh

Research output: Contribution to journalArticle

11 Scopus citations


Recent studies indicate that not all diabetic subjects benefit from aspirin therapy. Our objective is to characterize diabetic subjects with aspirin resistance using urine thromboxane, and VerifyNow measures. Our results suggest that cardiovascular disease, microalbuminuria, poor diabetes control, and increased waist circumference help identify aspirin resistance in diabetes.

Original languageEnglish (US)
Pages (from-to)e19-e21
JournalDiabetes Research and Clinical Practice
Issue number1
StatePublished - Oct 1 2010



  • Aspirin Resistance
  • Diabetes
  • Insulin Resistance
  • Platelets
  • Thrombosis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Yassine, H. N., Davis-Gorman, G., Stump, C. S., Thomson, S. S., Peterson, J., & McDonagh, P. F. (2010). Clinical determinants of aspirin resistance in diabetes. Diabetes Research and Clinical Practice, 90(1), e19-e21.